Bridgewater, NJ, United States of America

Sachin Mittal

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sachin Mittal: Pioneering Therapeutic Advances

Introduction: Sachin Mittal, an accomplished inventor based in Bridgewater, NJ, has made significant contributions to the field of pharmaceutical sciences. With a total of five patents, his innovative work primarily revolves around therapeutic compounds designed to address central nervous system disorders.

Latest Patents: Among his notable inventions is the patent for prodrugs of PDE10 compounds, specifically aimed at treating conditions associated with phosphodiesterase 10 (PDE10). This groundbreaking invention holds potential as a therapeutic agent for various neurological and psychiatric disorders, including schizophrenia, psychosis, and Huntington's disease. The prodrugs designed by Mittal are expected to play a crucial role in addressing issues linked with striatal hypofunction or basal ganglia dysfunction.

Career Highlights: Sachin Mittal's career has been marked by his tenure at prominent companies such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His experiences in these esteemed organizations have enriched his understanding and expertise in drug development, allowing him to contribute to innovative solutions in drug therapies.

Collaborations: Throughout his career, Sachin has collaborated with esteemed colleagues, including Jason W. Skudlarek and Izzat Tiedje Raheem. These collaborations have not only enhanced the research and development process but have also fostered an environment of knowledge sharing and innovation.

Conclusion: Sachin Mittal is a remarkable inventor whose patents and innovations pave the way for advancements in the treatment of central nervous system disorders. His continued efforts and collaborations in the pharmaceutical industry will undoubtedly contribute to groundbreaking therapies that enhance the quality of life for many individuals afflicted with debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…